These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3317294)

  • 1. Norfloxacin: clinical pharmacology and clinical use.
    Rowen RC; Michel DJ; Thompson JC
    Pharmacotherapy; 1987; 7(4):92-110. PubMed ID: 3317294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Holmes B; Brogden RN; Richards DM
    Drugs; 1985 Dec; 30(6):482-513. PubMed ID: 3908074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
    Nix DE; DeVito JM
    Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin: a new targeted fluoroquinolone antimicrobial agent.
    Wolfson JS; Hooper DC
    Ann Intern Med; 1988 Feb; 108(2):238-51. PubMed ID: 3277508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens.
    Digranes A; Dibb WL; Ostervold B
    Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):101-6. PubMed ID: 6233841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laboratory and clinical studies on norfloxacin in the pediatric field].
    Toyonaga Y; Koizumi M; Imai H; Sakaguchi N; Sugita M; Fukushima Y; Yamasaki M
    Jpn J Antibiot; 1990 May; 43(5):808-25. PubMed ID: 2391752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
    Guimaraes MA; Noone P
    J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R; Allocati N; Catamo G
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norfloxacin: a quinoline antibiotic.
    Marble DA; Bosso JA
    Drug Intell Clin Pharm; 1986 Apr; 20(4):261-6. PubMed ID: 3516615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory and clinical studies on norfloxacin in pediatrics].
    Sato Y; Iwata S; Akita H; Sunakawa K
    Jpn J Antibiot; 1990 May; 43(5):826-36. PubMed ID: 2391753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of norfloxacin against 1700 relatively resistant clinical isolates.
    Qadri SM; Lee G; Brodie L
    Drugs Exp Clin Res; 1989; 15(8):349-53. PubMed ID: 2598776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity.
    Goldstein EJ
    Am J Med; 1987 Jun; 82(6B):3-17. PubMed ID: 3111257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activity of AM-715, a new nalidixic acid analog.
    Ito A; Hirai K; Inoue M; Koga H; Suzue S; Irikura T; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Feb; 17(2):103-8. PubMed ID: 6446258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Norfloxacin: a broad-spectrum quinolone for superficial eye infections].
    Grosset J
    Pathol Biol (Paris); 1990 Sep; 38(7):735-41. PubMed ID: 2235090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative in-vitro activity of pefloxacin.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory and clinical studies of norfloxacin in pediatric field].
    Nishimura T; Tabuki K; Aoki S; Takagi M
    Jpn J Antibiot; 1990 May; 43(5):860-71. PubMed ID: 2391757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symposium on antimicrobial agents. The quinolones.
    Walker RC; Wright AJ
    Mayo Clin Proc; 1987 Nov; 62(11):1007-12. PubMed ID: 3312850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory and clinical studies of norfloxacin in respiratory tract infections].
    Kuwabara M; Muroki K; Fujiue Y; Ikeda M; Kodomari Y; Jyo T; Yamakido M
    Jpn J Antibiot; 1988 Jan; 41(1):1-9. PubMed ID: 3367509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of norfloxacin in the treatment of uncomplicated gonococcal urethritis: preliminary report.
    Cristiano P
    Drugs Exp Clin Res; 1989; 15(1):33-5. PubMed ID: 2501077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.